Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity

Curiel, Tyler J., Wei, Shuang, Dong, Haidong, Alvarez, Xavier, Cheng, Pui, Mottram, Peter, Krzysiek, Roman, Knutson, Keith L. +14 more·2003·Nature Medicine

DOI 10.1038/nm863

Cited by (1,000)

Items 801–900 of 1,000

Chitin induces upregulation of B7‐H1 on macrophages and inhibits T‐cell proliferation
Claudia Johanna Wagner, Silke Huber, Stefanie Wirth, David Voehringer · 2010 · European Journal of Immunology
Inhibition of protein kinase C by isojacareubin suppresses hepatocellular carcinoma metastasis and induces apoptosis in vitro and in vivo
Xing Yuan, Hao Chen, Xia Li, Ming Dai, Hua‐Wu Zeng, Lei Shan, Qingyan Sun, Weidong Zhang · 2015 · Scientific Reports
Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy
Aisha Nasreen Hasan, Annamalai Selvakumar · 2015 · Advancements in Genetic Engineering
Glycogen synthase 3 (GSK-3) regulation of PD-1 expression and and its therapeutic implications
Janna Krueger, Christopher E. Rudd, Alison Taylor · 2019 · Seminars in Immunology
Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence
Abdulaziz M. Eshaq, Thomas Wayne Flanagan, Abdulqader Ali Ba Abbad, Zain Alabden A. Makarem, Mohammed S. Bokir, Ahmed Khaled Alasheq, Sara A. Al Asheikh, Abdullah Mohammed Almashhor, Faroq Binyamani, Waleed A. Al-Amoudi et al. · 2024 · International Journal of Molecular Sciences
Frequent methylation of the tumour suppressor miR‐1258 targeting PDL1: implication in multiple myeloma‐specific cytotoxicity and prognostification
Lu Q. Wang, Shaji Kunnathu Kumar, George Adrian Calin, Zhenhai Li, Chor Sang Chim · 2020 · British Journal of Haematology
Interplay between inflammasomes and PD-1/PD-L1 and their implications in cancer immunotherapy
Zhongyu Jiao, Jun Zhang · 2023 · Carcinogenesis
Phenotype and tissue distribution of CD28H+immune cell subsets
Joel Crespo, Linda Vatan, Tomasz Maj, Rebecca Liu, Ilona Kryczek, Weiping Zou · 2017 · OncoImmunology
Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced‐stage ovarian cancer
Yong Jae Lee, Young Shin Chung, Jung‐Yun Lee, Eun Ji Nam, Sang Wun Kim, Sunghoon Kim, Young Tae Kim · 2019 · Cancer Medicine
Myrothecine A modulates the proliferation of HCC cells and the maturation of dendritic cells through downregulating miR-221
Yi Fu, Fengxia Li, Ping Zhang, Mingyan Liu, Li Qian, Fengwei Lv, Wenting Cheng, Ruixing Hou · 2019 · International Immunopharmacology
The anti-B7-H4 checkpoint synergizes trastuzumab treatment to promote phagocytosis and eradicate breast cancer
Xiaochen Hu, Yiwen Liu, Xiusen Zhang, Dejiu Kong, Jinyu Kong, Di Zhao, Yibo Guo, Lingyun Sun, Luoyi Chu, Shupei Liu et al. · 2020 · Neoplasia
Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas
Jacky T. Yeung, Vesal Yaghoobi, Thazin Nwe Aung, Matthew D. Vesely, Tianxiang Zhang, Patricia Gaule, Murat Günel, David L. Rimm, Lieping Chen · 2021 · Journal of Neuropathology & Experimental Neurology
IFNα Augments Clinical Efficacy of Regulatory T-cell Depletion with Denileukin Diftitox in Ovarian Cancer
Suzanne R. Thibodeaux, Brian B. Barnett, Srilakshmi Pandeswara, Shawna R. Wall, Vincent J. Hurez, Vinh A Dao, Lishi Sun, Benjamin J. Daniel, Michael J. Brumlik, Justin Michael Drerup et al. · 2021 · Clinical Cancer Research
Deep Sequencing of T-Cell Receptors for Monitoring Peripheral CD8+ T Cells in Chinese Advanced Non–Small-Cell Lung Cancer Patients Treated With the Anti–PD-L1 Antibody
Sheng Jin, Huadi Wang, Xiao Liu, Yunyun Deng, Yingying Yu, Pengfei Xu, Jiawei Shou, Hong Pan, Hongsen Li, Xiaoyun Zhou et al. · 2021 · Frontiers in Molecular Biosciences
B7-H3: another molecule marker for Mo-DCs?
Guangbo Zhang, Qiu-Ming Dong, Ying Xu, Gehua Yu, Xueguang Zhang · 2005 · PubMed
Recent Advances in Epitope Design for Immunotherapy of Cancer
Pieranna Chiarella, Emanuela Massi, Mariangela De Robertis, Vito Michele Fazio, Emanuela Signori · 2009 · Recent Patents on Anti-Cancer Drug Discovery
Augmenting the Potency of Breast Cancer Vaccines: Combined Modality Immunotherapy
Leisha A. Emens, R. Todd Reilly, Elizabeth M. Jaffee · 2004 · Breast Disease
CD8+ T Cells Induce Complete Regression of Advanced Ovarian Cancers by an Interleukin (IL)-2/IL-15–Dependent Mechanism
Taimei Yang, Erika M. Wall, Katy Milne, Patty M. Theiss, Peter Hamilton Watson, Brad H. Nelson · 2007 · Clinical Cancer Research
Locoregional Immune Checkpoint Blockade and Remodeling of Lymph Nodes by Engineered Dendritic Cell‐Derived Exosomes for Suppressing Tumor Progression and Metastasis
Yizhen Wang, Xiaomin Guo, Jingya Qin, Yifan Xue, Peng Zhang, Yadong Liu, Moyang Chen, Guanghao Zhu, Xinqiu Song, Lili Cheng et al. · 2025 · Advanced Science
Distinct transcriptomic and epigenomic responses of mature oligodendrocytes during disease progression in a mouse model of multiple sclerosis
Chao Zheng, Bastien Hervé, Mandy Meijer, L. A. Rubio Rodríguez-Kirby, André Ortlieb Guerreiro Cacais, P. Kukanja, Mukund Kabbe, Tony Jimenez-Beristain, Tomas Olsson, E. Agirre et al. · 2023 · bioRxiv
Immunotherapy for solid tumors—a review for surgeons
Abdul Saied Calvino, Venu Gopal Pillarisetty, Steven C. Katz · 2013 · Journal of Surgical Research
The Complement System in Ovarian Cancer: An Underexplored Old Path
Yaiza Senent, Daniel Ajona, Antonio González-Martı́n, Rubén Pı́o, Beatriz Tavira · 2021 · Cancers
Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials
Linwei Li, Qinglian Wen, Ruilin Ding · 2022 · Frontiers in Oncology
Disrupting the Interplay between Programmed Cell Death Protein 1 and Programmed Death Ligand 1 with Spherical Nucleic Acids in Treating Cancer
Liyushang Chou, Cassandra E. Callmann, Donye Dominguez, Bin Zhang, Chad Alexander Mirkin · 2022 · ACS Central Science
Interaction of glioma-associated microglia/macrophages and anti-PD1 immunotherapy
Chunhua Wang, Quan Chen, Meiqing Chen, Sizhen Guo, Ping Kang Hou, Yulian Zou, Jun Wang, Bailin He, Qiuyu Zhang, Lieping Chen et al. · 2023 · Cancer Immunology Immunotherapy
Programmed Death-1 & its Ligands: Promising Targets for Cancer Immunotherapy
Rajeev Kumar Shrimali, John Edward Janik, Rasha Abu Eid, Mikayel Mkrtichyan, Samir N. Khleif · 2015 · Immunotherapy
The synergistic strategies for the immuno‐oncotherapy with photothermal nanoagents
Yuqian Zhang, Guofang Zhang, Guocheng Wang, Lidong Wu, Nancy Ann Monteiro-Riviere, Yang Li · 2021 · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology
Programmed death 1: a critical regulator of T-cell function and a strong target for immunotherapies for chronic viral infections
Lydie Trautmann, Elias Anthony Said, Rabih Halwani, Loury Janbazian, Nicolas Chomont, Mohamed El Far, Gaëlle Breton, Elias K. Haddad, Rafick‐Pierre Sékaly · 2007 · Current Opinion in HIV and AIDS
Expression of Costimulatory Molecules on Human Retinoblastoma Cells Y-79: Functional Expression of CD40 and B7H1
Yoshihiko Usui, Youko Okunuki, Takaaki Hattori, Masaru Takeuchi, Takeshi Kezuka, Hiroshi Gotô, Masahiko Usui · 2006 · Investigative Ophthalmology & Visual Science
Functional Regulation of Ginsenosides on Myeloid Immunosuppressive Cells in the Tumor Microenvironment
Yanfei Zhang, Zhidong Qiu, Ye Qiu, Ting Su, Peng Qu, Ailing Jia · 2019 · Integrative Cancer Therapies
Inflammatory Diseases - A Modern Perspective
Amit Nagal · 2011 · InTech eBooks
Lysosomal acid lipase, CSF1R, and PD-L1 determine functions of CD11c+ myeloid-derived suppressor cells
Ting Zhao, Sheng Liu, Xinchun Ding, Erica M. Johnson, Nasser H. Hanna, Kanhaiya Singh, Chandan K. Sen, Jun Wan, Hong Du, Cong Yan · 2022 · JCI Insight
Current studies and future promises of PD-1 signal inhibitors in cervical cancer therapy
Annoor Awadasseid, Yongnan Zhou, Koutian Zhang, Kaiming Tian, Yanling Wu, Wen Zhang · 2022 · Biomedicine & Pharmacotherapy
Expression of Cartilage Oligomeric Matrix Protein in colorectal cancer is an adverse prognostic factor and correlates negatively with infiltrating immune cells and PD-L1 expression
Anna Marie Blom, Chrysostomi Gialeli, Catharina Hagerling, Jonna Berntsson, Karin Jirström, Κωνσταντίνος Σ. Παπαδάκος · 2023 · Frontiers in Immunology
Ovarian Tumor-Induced T Cell Suppression Is Alleviated by Vascular Leukocyte Depletion
S. Bąk, G. Bak, Kevin M. Hart, Brent L. Berwin · 2009 · Translational Oncology
Radiotherapy suppressed tumor-specific recruitment of regulator T cells via up-regulating microR-545 in Lewis lung carcinoma cells.
Liao Chen, Wei Lie Xiao, Nuo Zhu, Zhiyuan Liu, Jiu Yang, Yanhu Wang, Mei Hong · 2015 · PubMed Central
Strategies to Genetically Modulate Dendritic Cells to Potentiate Anti-Tumor Responses in Hematologic Malignancies
Annelisa M. Cornel, Niek Peter van Til, Jaap Jan Boelens, Stefan Nierkens · 2018 · Frontiers in Immunology
Prognostic impact of programmed cell death ligand 1 expression on long‑term oncologic outcomes in colorectal cancer
Sung Uk Bae, Woon Kyung Jeong, Seong Kyu Baek, Nam Kyu Kim, Ilseon Hwang · 2018 · Oncology Letters
Hypoxia and the Tumor Secretome
Ying Liu, Gabrielle E. Ciotti, T.S. Karin Eisinger‐Mathason · 2019 · Advances in experimental medicine and biology
B7-H1 Expression Is Required for Human Endometrial Regenerative Cells in the Prevention of Transplant Vasculopathy in Mice
Kui Ye, Lan Xu, Grace Wang, Baoren Zhang, Xiaoxi Xu, Xiang Li, Yiming Zhao, Hao Wang · 2018 · Stem Cells International
Therapeutic lymphoma vaccines: importance of T-cell immunity
Sattva Swarup Neelapu, Seung‐Tae Lee, Hong Qin, Soung-chul Cha, Alison F. Woo, Larry W. Kwak · 2006 · Expert Review of Vaccines
Targeting Programmed Cell Death 1 in Ovarian Cancer
Krisztián Homicskó, George Coukos · 2015 · Journal of Clinical Oncology
Echinacoside inhibits tumor immune evasion by downregulating inducible PD-L1 and reshaping tumor immune landscape in breast and colorectal cancer
Xiaoyu Wang, Binxin Tan, Jiazhou Liu, Jing Wang, Mingjing Chen, Qian Yang, Xiang Zhang, Fan Li, Yuxian Wei, Ke Wu et al. · 2024 · Phytomedicine
Antigen cross-presentation in young tumor-bearing hosts promotes CD8 + T cell terminal differentiation
Ardiana Moustaki, Jeremy Chase Crawford, Shanta Alli, Yiping Fan, Shannon Kathryn Boi, Anthony Elston Zamora, Natalie McDonald, Gang Wu, Joy Nakitandwe, Scott Newman et al. · 2022 · Science Immunology
Anlotinib combined with the PD-L1 blockade exerts the potent anti-tumor immunity in renal cancer treatment
Jie Li, Peiyu Cao, Yuxin Chen, Junqi Wang, Xiaolei Sun, Renfu Chen, Gang Wang, Jianquan Hou · 2022 · Experimental Cell Research
KLRF1 , a novel marker of CD56bright NK cells, predicts improved survival for patients with locally advanced bladder cancer
Neelam Z. Mukherjee, Niannian Ji, Xi Tan, Chun‐Liang Chen, Onika D. V. Noel, Maria Rodriguez‐Padron, Chun‐Lin Lin, David G. Alonzo, Tim H.‐M. Huang, Robert Scott Svatek · 2022 · Cancer Medicine
Enhancement of immune surveillance in breast cancer by targeting hypoxic tumor endothelium: Can it be an immunological switch point?
Juvin Ann Thomas, Athira Gireesh Gireesh Moly, Hima Xavier, Priya Suboj, Amit Ladha, Gaurav Gupta, Santosh Kumar Singh, Partha Palit, Suboj Babykutty · 2023 · Frontiers in Oncology
Analysis of PD-1 related immune transcriptional profile in different cancer types
Jun Shang, Qian Song, Zuyi Yang, Xiaoyan Sun, Meijuan Xue, Wenjie Chen, Jingcheng Yang, Sihua Wang · 2018 · Cancer Cell International
Perspectives on immune checkpoint ligands: expression, regulation, and clinical implications
Jihyun Moon, Yoo Min Oh, Sang‐Jun Ha · 2021 · BMB Reports
Uncovering the Immunoregulatory Function and Therapeutic Potential of the PD-1/PD-L1 Axis in Cancer
Michael Reginald Pitter, Weiping Zou · 2021 · Cancer Research
Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro
Shuo Wang, Jing Liu, Shixiu Shao, Xianjun Li, Jiannan Gao, Haitao Niu, Xinsheng Wang, Yonghua Wang · 2014 · OncoTargets and Therapy
Expression and clinical significance of PD‑1 in hepatocellular carcinoma tissues detected by a novel mouse anti-human PD‑1 monoclonal antibody
Ziwei Li, Bin Li, Dan Peng, Haiyan Xing, Guanying Wang, Li Pan, Jiming Wang, George Ye, Jianhong Chen · 2018 · International Journal of Oncology
Combination pembrolizumab plus chemotherapy: a new standard of care for patients with advanced non-small-cell lung cancer
Frank D. Weinberg, Shirish M. Gadgeel · 2019 · Lung Cancer Targets and Therapy
MUC1‑induced immunosuppression in colon cancer can be reversed by blocking the PD1/PDL1 signaling pathway
Yinghui Zhang, Xiangqian Dong, Liping Bai, Xueqin Shang, Yujian Zeng · 2020 · Oncology Letters
Synopsis of the 6th Walker's Cay Colloquium on Cancer Vaccines and Immunotherapy
W. Martin Kast, Hyam I. Levitsky, Francesco Maria Marincola · 2004 · Journal of Translational Medicine
Antisense therapy for restenosis following percutaneous coronary intervention
Nicholas N Kipshidze, Mykola V. Tsapenko, Patrick L. Iversen, Denis R. Burger · 2005 · Expert Opinion on Biological Therapy
PD-L1-CD80 interactions are required for intracellular signaling necessary for dendritic cell migration
Uma Kantheti, Tadg S. Forward, Erin D. Lucas, Johnathon B. Schafer, Pierce J. Tamburini, Matthew A. Burchill, Beth A. Jirón Tamburini · 2025 · Science Advances
Immune modulatory vaccines targeting tumor microenvironment antigens: recent advances in oncology and beyond
Mads Hald Andersen · 2026 · Signal Transduction and Targeted Therapy
Prospective immunotherapies in childhood sarcomas: PD1/PDL1 blockade in combination with tumor vaccines
Theodore Scott Nowicki, Jennifer Lynn Anderson, Noah C. Federman · 2015 · Pediatric Research
Combination of immune checkpoint inhibitors and tyrosine kinase inhibitors for the treatment of renal cell carcinoma
Viktoria Stühler, Steffen Rausch, Jan Moritz Maas, Arnulf Stenzl, Jens Bedke · 2021 · Expert Opinion on Biological Therapy
Considerations and Approaches for Cancer Immunotherapy in the Aging Host
Carlos Oscar Ontiveros, Clare E. Murray, Grace E. Crossland, Tyler Jay Curiel · 2023 · Cancer Immunology Research
Single-cell and transcriptomic analyses reveal the influence of diabetes on ovarian cancer
Zhihao Zhao, Qilin Wang, Fang Zhao, Junnan Ma, Xue Sui, Hyok Chol Choe, Peng Chen, Xue Gao, Lin Zhang · 2024 · BMC Genomics
Immunotherapy for Ovarian Cancer: Disappointing or Promising?
Mengqi Deng, Fan Tang, Xiangyu Chang, Penglin Liu, Xuechao Ji, Menglin Hao, Yixiao Wang, Ruiye Yang, Qingqing Ma, Yubo Zhang et al. · 2024 · Molecular Pharmaceutics
Beyond Chemotherapies: Recent Strategies in Breast Cancer Treatment
Arthur Foulon, Pierrick Theret, Lise Rodat‐Despoix, Philippe Kischel · 2020 · Cancers
Localization of FOXP3-positive cells in renal cell carcinoma
Katharina Sell, Peter Josef Barth, Roland Moll, Martin A. Thomas, Nadine Zimmer, Ecatarina Oplesch, Michael Gudo, Mark G. Schrader, Rainer W. Hofmann, Andres Jan Schrader · 2011 · Tumor Biology
Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
Inês Costa, Steffen Rausch, Stephan Kruck, Tilman Todenhöfer, Arnulf Stenzl, Jens Bedke · 2017 · Expert Review of Anticancer Therapy
Are dendritic cells the most appropriate therapeutic vaccine for patients with ovarian cancer?
Silvia Martin Lluesma, Michele Graciotti, Alizée J Grimm, Caroline Boudousquié, Cheryl Lai-Lai Chiang, Lana Elias Kandalaft · 2020 · Current Opinion in Biotechnology
Recent advances of molecular mechanisms of regulating PD-L1 expression in melanoma
Jiaqian Han, Xiaobo Xu, Zi Liu, Zengqiang Li, Yingliang Wu, Daiying Zuo · 2020 · International Immunopharmacology
Activation of Tolerogenic Dendritic Cells in the Tumor Draining Lymph Nodes by CD8+ T Cells Engineered to Express CD40 Ligand
Eileen M. Higham, Karl Dane Wittrup, Jianzhu Chen · 2010 · The Journal of Immunology
The Programmed Death-1 and Interleukin-10 Pathways Play a Down-Modulatory Role in LP-BM5 Retrovirus-Induced Murine Immunodeficiency Syndrome
Kathy A. Green, Taku Okazaki, Tasuku Honjo, W. James Cook, William R. Green · 2007 · Journal of Virology
EphA10 drives tumor progression and immune evasion by regulating the MAPK/ERK cascade in lung adenocarcinoma
Wenyue Zhao, Lu Liu, Xuehao Li, Shun Qing Xu · 2022 · International Immunopharmacology
IGFBP3 induces PD-L1 expression to promote glioblastoma immune evasion
Leilei Zhao, Yudi Wang, Peizheng Mu, Xuehua Zhang, Ruomei Qi, Yurui Zhang, He Zhang, Xiao Min Zhu, Zhou-Yan Dong, Yucui Dong · 2024 · Cancer Cell International
IFNγ-Induced Bcl3, PD-L1 and IL-8 Signaling in Ovarian Cancer: Mechanisms and Clinical Significance
S Paddy Reddy, Fatema Zohra Sadia, Aleš Vančura, Ivana Vancurova · 2024 · Cancers
The roles of migrasomes in immunity, barriers, and diseases
Changsheng Cai, Jun Shen · 2024 · Acta Biomaterialia
Influence of gut microbial metabolites on tumor immunotherapy: mechanisms and potential natural products
Dongyang Li, Xintian Lan, Linyi Xu, Shuo Zhou, Haoming Luo, Xiaoying Zhang, Wenbo Yu, Yonggang Yang, Xiaoxue Fang · 2025 · Frontiers in Immunology
Potentiation strategies of dendritic cell-based antitumor vaccines: combinational therapy takes the front seat
Monireh Torabi‐Rahvar, Mahmood Bozorgmehr, Mahmood Jeddi‐Tehrani, Amir‐Hassan Zarnani · 2011 · Drug Discovery Today
An update on the pharmacodynamics, pharmacokinetics, safety and clinical efficacy of nivolumab in the treatment of solid cancers
Chi Yan Wong, Brigette B.Y. Ma · 2016 · Expert Opinion on Drug Metabolism & Toxicology
Clinical Development of PD-1 Blockade in Hematologic Malignancies
Matthew James Pianko, Aaron D. Goldberg, Alexander M. Lesokhin · 2018 · The Cancer Journal
Soluble PD-L1: a potential immune marker for HIV-1 infection and virological failure
José Avendaño Ortiz, Marina Rubio-Garrido, Roberto Lozano‐Rodríguez, Jorge del Romero, Carmen Rodríguez, Santiago Moreno, Luis Augusto Aguirre, África Holguín, Eduardo López‐Collazo · 2020 · Medicine
The Influence of the microbiome on the innate immune microenvironment of solid tumors
Angel M. Charles, Ryan Michael Thomas · 2023 · Neoplasia
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
Jabar A. Faraj, Ali Jihad Hemid Al-Athari, Sharaf El Din Mohie, Iman Kareem Kadhim, Noor Muhsen Jawad, Weaam J. Abbas, Abduladheem Turki Jalil · 2022 · Medical Oncology
Head and neck cancer immunotherapy: Clinical evaluation
Michael S. Leibowitz, Jayakar V. Nayak, Robert Louis Ferris · 2008 · Current Oncology Reports
Human CD4+ regulatory T cells and activation-induced tolerance
Ehud Hauben, Maria Grazia Roncarolo · 2005 · Microbes and Infection
Regulation of Tumor Dendritic Cells by Programmed Cell Death 1 Pathways
Keith L. Knutson · 2024 · The Journal of Immunology
Noncanonical PD-1/PD-L1 Axis in Relation to the Efficacy of Anti-PD Therapy
Yiru Long, Xiaolu Yu, Runqiu Chen, Yongliang Tong, Likun Gong · 2022 · Frontiers in Immunology
Metabolic and senescence characteristics associated with the immune microenvironment in ovarian cancer
Jian Xiong, Yiyuan Fu, Jiezheng Huang, Yibin Wang, Xiaolong Jin, Xiaoyan Wan, Liu Huang, Zheng Huang · 2023 · Frontiers in Endocrinology
An innovative antibody fusion protein targeting PD-L1, VEGF and TGF-β with enhanced antitumor efficacies
Wenlu Fan, Yonglu Chen, Zhenxing Zhou, Wenwen Duan, Chengcheng Yang, Shimei Sheng, Yongwei Wang, Xinru Wei, Ying Liu, Yanshan Huang · 2024 · International Immunopharmacology
Psoriasis de novo or exacerbation by PD-1 checkpoint inhibitors
Zi Wan, Jiangyuan Huang, Xiao-Jie Ou, Shuang Lou, Jian-Ji Wan, Zhu Shen · 2024 · Anais Brasileiros de Dermatologia
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, Amin Ramezani · 2025 · Cellular Oncology
Identification of Human Idiotype-Specific T Cells in Lymphoma and Myeloma
Jinsheng Weng, Sattva Swarup Neelapu, Alison F. Woo, Larry W. Kwak · 2010 · Current topics in microbiology and immunology
CD137 ligand feedback upregulates PD‐L1 expression on lung cancer via T cell production of IFN‐γ
Helin Wang, Zhuohong Yan, Jianqing Hao, Bin Yang, Jinghui Wang, Ling Yi, Xiaojue Wang, Shuping Li, Hongtao Zhang, Shucai Zhang · 2019 · Thoracic Cancer
Cancer-associated fibroblasts: Just on the opposite side of antitumour immunity?
Shuaiqingying Guo, Jing Yuan, Xiaolin Meng, Xue Feng, Ding Ma, Yingyan Han, Kezhen Li · 2023 · International Immunopharmacology
Immune targeting of PD-1hi expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques
Diego A. Vargas‐Inchaustegui, Peng Xiao, Alison E. Hogg, Thorsten Demberg, Katherine M. McKinnon, David J. Venzon, Egidio Brocca‐Cofano, Janet DiPasquale, Eun M. Lee, Lauren Hudacik et al. · 2013 · Virology
Dendritic Cell Vaccination, Immune Regulation, and Clinical Outcomes in Ovarian Cancer
Hannah E. Goyne, Martin J. Cannon · 2013 · Frontiers in Immunology
B1 Lymphocytes and Myeloid Dendritic Cells in Lymphoid Organs Are Preferential Extratumoral Sites of Parvovirus Minute Virus of Mice Prototype Strain Expression
Zahari Raykov, Larissa Savelyeva, Ginette Balboni, Thomas Giese, Jean Rommelaere, Nathalia A. Giese · 2005 · Journal of Virology
Escherichia coli K12 Upregulates Programmed Cell Death Ligand 1 (PD-L1) Expression in Gamma Interferon-Sensitized Intestinal Epithelial Cells via the NF-κB Pathway
Seul A. Lee, Yiming Wang, Fang Liu, Stephen M. Riordan, Lu Liu, Li Zhang · 2020 · Infection and Immunity
Cancer vaccines: the challenge of developing an ideal tumor killing system
Simone Mocellin M. D · 2005 · Frontiers in bioscience
Hepatocellular cancer therapy in patients with HIV infection: Disparities in cancer care, trials enrolment, and cancer-related research
Francesca Negri, Gabriele Missale, Anna Degli Antoni, Camillo Porta · 2021 · Translational Oncology
PD-L1: Can it be a biomarker for the prognosis or a promising therapeutic target in cervical cancer?
Ruizhe Wang, Yi Zhang, Fengping Shan · 2021 · International Immunopharmacology
PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis
Dakota B. Poschel, John David Klement, Alyssa D. Merting, Chunwan Lu, Yang Zhao, Dafeng Yang, Wei Lie Xiao, Huabin Zhu, Ponnala Rajeshwari, Michael L. Toscano et al. · 2024 · Cell Reports